Effects of socioeconomic position on inflammatory and hemostatic markers: A life-course analysis in the 1958 British birth cohort

American Journal of Epidemiology

Volumn 167, Issue 11, 2008, Pages 1332-1341

  Tabassum, Faiza ^a   Kumari, Meena ^a   Rumley, Ann ^b   Lowe, Gordon ^b   Power, Chris ^c   Strachan, David P ^d  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

C reactive protein; Cohort studies; Fibrinogen; Hemostasis; Inflammation; Social class; Tissue plasminogen activator; Von Willebrand factor

Indexed keywords

C REACTIVE PROTEIN; FIBRINOGEN; TISSUE PLASMINOGEN ACTIVATOR; VON WILLEBRAND FACTOR;

ANTIGEN; BODY CONDITION; CARDIOVASCULAR DISEASE; COHORT ANALYSIS; ENZYME ACTIVITY; HEALTH RISK; IMMUNE RESPONSE; PROTEIN; RISK FACTOR; SOCIOECONOMIC CONDITIONS;

ADULT; ADULTHOOD; ARTICLE; BIRTH; BODY MASS; CARDIOVASCULAR RISK; CHILDHOOD; DATA ANALYSIS; FEMALE; HEMOSTASIS; HUMAN; INFLAMMATION; ISCHEMIC HEART DISEASE; MALE; PHYSICAL ACTIVITY; RISK FACTOR; SCORING SYSTEM; SMOKING; SOCIAL CLASS; SOCIOECONOMICS;

ADULT; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; ENGLAND; FEMALE; FIBRINOGEN; HUMANS; MALE; MIDDLE AGED; REGRESSION ANALYSIS; SOCIAL CLASS; TISSUE PLASMINOGEN ACTIVATOR; VON WILLEBRAND FACTOR;

EURASIA; EUROPE; UNITED KINGDOM; WESTERN EUROPE;

EID: 44449138148     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwn055     Document Type: Article

References (47)

1. Danesh J, Wheeler JG, Hirschfield GM, et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 2004;350:1387-97.
2. Danesh J, Lewington S, Thompson SG, et al. Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA 2005;294:1799-809.
3. Lowe GD, Danesh J, Lewington S, et al. Tissue plasminogen activator antigen and coronary heart disease. Prospective study and meta-analysis. Eur Heart J 2004;25:252-9.
4. Ridker PM, Buring JE, Cook NR, et al. C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women. Circulation 2003;107:391-7.
5. Whincup PH, Danesh J, Walker M, et al. von Willebrand factor antigen and coronary heart disease: prospective study and meta-analysis. Eur Heart J 2002;23:1764-70.
6. Cushman M, Arnold AM, Psaty BM, et al. C-reactive protein and the 10-year incidence of coronary heart disease in older men and women: The Cardiovascular Health Study. Circulation 2005;112:25-31.
7. Folsom AR, Chambless LE, Ballantyne CM, et al. An assessment of incremental coronary risk prediction using C-reactive protein and other novel risk markers: The Atherosclerosis Risk in Communities Study. Arch Intern Med 2006;166:1368-73.
8. Lowe GD. Circulating inflammatory markers and risks of cardiovascular and non-cardiovascular disease. J Thromb Haemost 2005;3:1618-27.
9. Koster A, Bosma H, Penninx BW, et al. Association of inflammatory markers with socioeconomic status. J Gerontol A Biol Sci Med Sci 2006;61:284-90.
10. Brunner E, Davey SG, Marmot M, et al. Childhood social circumstances and psychosocial and behavioural factors as determinants of plasma fibrinogen. Lancet 1996;347:1008-13.
11. Brunner EJ, Marmot MG, White IR, et al. Gender and employment grade differences in blood cholesterol, apolipoproteins and haemostatic factors in the Whitehall II Study. Atherosclerosis 1993;102:195-207.
12. Hemingway H, Shipley M, Mullen MJ, et al. Social and psychosocial influences on inflammatory markers and vascular function in civil servants (the Whitehall II Study). Am J Cardiol 2003;92:984-7.
13. Jousilahti P, Salomaa V, Rasi V, et al. Association of markers of systemic inflammation, C reactive protein, serum amyloid A, and fibrinogen, with socioeconomic status. J Epidemiol Community Health 2003;57:730-3.
14. Kumari M, Marmot M, Brunner E. Social determinants of von Willebrand factor: The Whitehall II Study. Arterioscler Thromb Vasc Biol 2000;20:1842-7.
15. Loucks EB, Sullivan LM, Hayes LJ, et al. Association of educational level with inflammatory markers in the Framingham Offspring Study. Am J Epidemiol 2006;163:622-8.
16. Wilson TW, Kaplan GA, Kauhanen J, et al. Association between plasma fibrinogen concentration and five socioeconomic indices in the Kuopio Ischemic Heart Disease Risk Factor Study. Am J Epidemiol 1993;137:292-300.
17. Markowe HL, Marmot MG, Shipley MJ, et al. Fibrinogen: a possible link between social class and coronary heart disease. Br Med J (Clin Res Ed) 1985;291:1312-14.
18. Alley DE, Seeman TE, Ki KJ, et al. Socioeconomic status and C-reactive protein levels in the US population: NHANES IV. Brain Behav Immun 2006;20:498-504.
19. Brunner E, Shipley MJ, Blane D, et al. When does cardiovascular risk start? Past and present socioeconomic circumstances and risk factors in adulthood. J Epidemiol Community Health 1999;53:757-64.
20. Power C, Atherton K, Strachan DP, et al. Life-course influences on health in British adults: effects of socio-economic position in childhood and adulthood. Int J Epidemiol 2007;36:532-9.
21. Galobardes B, Smith GD, Lynch JW. Systematic review of the influence of childhood socioeconomic circumstances on risk for cardiovascular disease in adulthood. Ann Epidemiol 2006;16:91-104.
22. Lawlor DA, Smith GD, Ebrahim S. Association between childhood socioeconomic status and coronary heart disease risk among postmenopausal women: findings from the British Women's Heart and Health Study. Am J Public Health 2004;94:1386-92.
23. Singh-Manoux A, Ferrie JE, Chandola T, et al. Socioeconomic trajectories across the life course and health outcomes in midlife: evidence for the accumulation hypothesis? Int J Epidemiol 2004;33:1072-9.
24. Smith GD, Hart C, Blane D, et al. Lifetime socioeconomic position and mortality: prospective observational study. BMJ 1997;314:547-52.
25. Wamala SP, Lynch J, Kaplan GA. Women's exposure to early and later life socioeconomic disadvantage and coronary heart disease risk: The Stockholm Female Coronary Risk Study. Int J Epidemiol 2001;30:275-84.
26. Lynch JW, Kaplan GA, Shema SJ. Cumulative impact of sustained economic hardship on physical, cognitive, psychological, and social functioning. N Engl J Med 1997;337:1889-95.
27. Rosvall M, Ostergren PO, Hedblad B, et al. Life-course perspective on socioeconomic differences in carotid atherosclerosis. Arterioscler Thromb Vasc Biol 2002;22:1704-11.
28. Hallqvist J, Lynch J, Bartley M, et al. Can we disentangle life course processes of accumulation, critical period and social mobility? An analysis of disadvantaged socio-economic positions and myocardial infarction in the Stockholm Heart Epidemiology Program. Soc Sci Med 2004;58:1555-62.
29. Power C, Elliott J. Cohort profile: 1958 British birth cohort (National Child Development Study). Int J Epidemiol 2006;35:34-41.
30. Atherton K, Fuller E, Shepherd P, et al. Loss and representativeness in a biomedical survey at age 45 years: 1958 British birth cohort. J Epidemiol Community Health 2008;62:216-23.
31. Strachan DP, Rudnicka AR, Power C, et al. Lifecourse influences on health among British adults: effects of region of residence in childhood and adulthood. Int J Epidemiol 2007;36:522-31.
32. Libby P. Inflammation and cardiovascular disease mechanisms. Am J Clin Nutr 2006;83(suppl):456S-60S.
33. Lynch J, Kaplan GA, Salonen R, et al. Socioeconomic status and progression of carotid atherosclerosis. Prospective evidence from the Kuopio Ischemic Heart Disease Risk Factor Study. Arterioscler Thromb Vasc Biol 1997;17:513-19.
34. Lowe GD, Rumley A, Whincup PH, et al. Hemostatic and rheological variables and risk of cardiovascular disease. Semin Vasc Med 2002;2:429-39.
35. Libby P. Inflammation in atherosclerosis. Nature 2002;420:868-74.
36. Charakida M, Donald AE, Terese M, et al. Endothelial dysfunction in childhood infection. Circulation 2005;111:1660-5.
37. Martin H, Hu J, Gennser G, et al. Impaired endothelial function and increased carotid stiffness in 9-year-old children with low birthweight. Circulation 2000;102:2739-44.
38. Lawlor DA, Smith GD, Rumley A, et al. Associations of fibrinogen and C-reactive protein with prevalent and incident coronary heart disease are attenuated by adjustment for confounding factors. British Women's Heart and Health Study. Thromb Haemost 2005;93:955-63.
39. Ben Shlomo Y, Kuh D. A life course approach to chronic disease epidemiology: conceptual models, empirical challenges and interdisciplinary perspectives. Int J Epidemiol 2002;31:285-93.
40. Blane D, Hart CL, Smith GD, et al. Association of cardiovascular disease risk factors with socioeconomic position during childhood and during adulthood. BMJ 1996;313:1434-8.
41. Kuh D, Smith GD. The life course and adult chronic disease: an historical perspective with particular reference to coronary heart disease. In: Kuh D, Ben Shlomo Y, eds. A life course approach to chronic disease epidemiology. New York: Oxford University Press 2004:15-41.
42. Kuh D, Ben Shlomo Y, Lynch J, et al. Life course epidemiology. J Epidemiol Community Health 2003;57:778-83.
43. Kivimaki M, Lawlor DA, Juonala M, et al. Lifecourse socioeconomic position, C-reactive protein, and carotid intimamedia thickness in young adults: The Cardiovascular Risk in Young Finns Study. Arterioscler Thromb Vasc Biol 2005;25:2197-202.
44. Adler NE, Ostrove JM. Socioeconomic status and health: what we know and what we don't. Ann N Y Acad Sci 1999;896:3-15.
45. Wannamethee SG, Lowe GD, Whincup PH, et al. Physical activity and hemostatic and inflammatory variables in elderly men. Circulation 2002;105:1785-90.
46. Wannamethee SG, Lowe GD, Shaper AG, et al. Associations between cigarette smoking, pipe/cigar smoking, and smoking cessation, and haemostatic and inflammatory markers for cardiovascular disease. Eur Heart J 2005;26:1765-73.
47. Reaven GM, Scott EM, Grant PJ, et al. Hemostatic abnormalities associated with obesity and the metabolic syndrome. J Thromb Haemost 2005;3:1074-85.